The clinical core (Core B) of the CCNMD will provide recruitment, assessment, diagnostic, tracking and referral services to the projects of the CCNMD. These projects include both post-mortem neuropathological assessment and sophisticated neuroimaging studies. Patients with schizophrenia with a wide range of severity of illness and functional outcome will be recruited, including patients who have experienced only two episodes of illness to patients with a continuous institutional stay approaching seven decades. Recruitment will be facilitated by an existing network of research sites, including 4 VA hospitals (funded by a VA MIRECC award), a large public psychiatric hospital, an academic medical center, and multiple community clinics and nursing homes. These sites have already yielded a cohort of over 1,500 geriatric patients with schizophrenia, who will continue to participate in the different studies in this proposed CCNMD. Using previously validated techniques, a research quality diagnosis will be ascertained on all patients, using both structured psychiatric interviews and formalized chart review procedures. Assessments, including clinical symptoms, cognitive functions, and functional skills, as well as health status and movement disorders, will also be performed on all patients. These assessments have been implemented in multiple studies previously of this population and have been carefully selected, updated, and modified to reflect the characteristics of the patients examined. These assessments will be continuously evaluated for the reliability. Furthermore, all patients will be tracked, using procedures developed over the past twelve years, in order to maintain contact with them as members of a large longitudinal cohort of well-assessed patients with schizophrenia. The information collected by this core will be immediately disseminated to the Brain Bank Core (Core C), Data Management and Statistics Core (Core D), and the PIs of individual projects. Leaders of this core will be in constant contact with the directors of other cores and projects to allow for updating of the recruitment and assessment goals in response to the findings of the studies and the rate of recruitment.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
1P50MH066392-01
Application #
6697228
Study Section
Special Emphasis Panel (ZMH1)
Project Start
2002-09-30
Project End
2006-07-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
DUNS #
114400633
City
New York
State
NY
Country
United States
Zip Code
10029
Amiri, Anahita; Coppola, Gianfilippo; Scuderi, Soraya et al. (2018) Transcriptome and epigenome landscape of human cortical development modeled in organoids. Science 362:
Giambartolomei, Claudia; Zhenli Liu, Jimmy; Zhang, Wen et al. (2018) A Bayesian framework for multiple trait colocalization from summary association statistics. Bioinformatics 34:2538-2545
Toker, Lilah; Mancarci, Burak Ogan; Tripathy, Shreejoy et al. (2018) Transcriptomic Evidence for Alterations in Astrocytes and Parvalbumin Interneurons in Subjects With Bipolar Disorder and Schizophrenia. Biol Psychiatry 84:787-796
Huckins, L M; Hatzikotoulas, K; Southam, L et al. (2018) Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa. Mol Psychiatry 23:1169-1180
Wang, Daifeng; Liu, Shuang; Warrell, Jonathan et al. (2018) Comprehensive functional genomic resource and integrative model for the human brain. Science 362:
Mitchell, A C; Javidfar, B; Pothula, V et al. (2018) MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice. Mol Psychiatry 23:123-132
Bryois, Julien; Garrett, Melanie E; Song, Lingyun et al. (2018) Evaluation of chromatin accessibility in prefrontal cortex of individuals with schizophrenia. Nat Commun 9:3121
Fazio, Leonardo; Pergola, Giulio; Papalino, Marco et al. (2018) Transcriptomic context of DRD1 is associated with prefrontal activity and behavior during working memory. Proc Natl Acad Sci U S A 115:5582-5587
Gusev, Alexander; Mancuso, Nicholas; Won, Hyejung et al. (2018) Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights. Nat Genet 50:538-548
Mitelman, Serge A; Bralet, Marie-Cecile; Mehmet Haznedar, M et al. (2018) Positron emission tomography assessment of cerebral glucose metabolic rates in autism spectrum disorder and schizophrenia. Brain Imaging Behav 12:532-546

Showing the most recent 10 out of 153 publications